H Cyte Inc Asset Turnover Ratio (HCYT), as of first quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
H cyte Inc  (HCYT)
 

H Cyte Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Mar 31 2023, H Cyte Inc has not recorded any assets.
Visit H Cyte Inc Balance sheet

Within sector H cyte Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the First Quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HCYT Asset Turnover Ratio (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Asset Change -45.62 % -61.74 % -68.43 % -86.33 % -33.25 %
Y / Y Revenue Change - -100 % - -83.59 % 0.9 %
Asset Turnover Ratio (TTM) - 1.47 - 2.61 1.81
HCYT's Total Ranking # # # # #
Seq. Asset Change 179.31 % -42.66 % -19.14 % -58.01 % 96.55 %
Seq. Revenue Change - - - -80.53 % 16.9 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




HCYT Company Profile • Back to HCYT Efficiency Comparisons • Compare HCYT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2023 Assets at quarter ending Mar 31 2023
Moderna Inc   0.59 $ 15,059.000  Millions$ 25,520.500  Millions
Amneal Pharmaceuticals Inc   0.59 $ 2,258.884  Millions$ 3,835.348  Millions
Spero Therapeutics Inc   0.59 $ 53.509  Millions$ 91.363  Millions
Siga Technologies Inc  0.58 $ 108.559  Millions$ 185.781  Millions
Iqvia Holdings Inc   0.58 $ 14,494.000  Millions$ 24,928.000  Millions
Myriad Genetics Inc   0.58 $ 694.700  Millions$ 1,197.550  Millions
Zoetis Inc   0.58 $ 8,094.000  Millions$ 14,030.750  Millions
Alkermes Plc   0.58 $ 1,120.845  Millions$ 1,946.505  Millions
Neuronetics Inc   0.58 $ 66.565  Millions$ 115.669  Millions
Dexcom Inc   0.58 $ 3,022.500  Millions$ 5,256.050  Millions
Organon and Co   0.57 $ 6,145.000  Millions$ 10,692.250  Millions
Adapthealth Corp   0.57 $ 3,009.018  Millions$ 5,235.755  Millions
Seagen Inc   0.57 $ 2,055.671  Millions$ 3,616.812  Millions
Acadia Healthcare Company Inc   0.57 $ 2,817.622  Millions$ 4,964.475  Millions
Vapotherm Inc   0.57 $ 62.910  Millions$ 111.151  Millions
Adma Biologics Inc   0.57 $ 181.890  Millions$ 321.685  Millions
Ati Physical Therapy Inc   0.57 $ 648.781  Millions$ 1,147.903  Millions
Abbott Laboratories  0.56 $ 41,505.000  Millions$ 73,808.750  Millions
Eli Lilly And Company  0.56 $ 27,691.400  Millions$ 49,294.475  Millions
Cytosorbents Corporation  0.56 $ 35.447  Millions$ 63.542  Millions
Nuvasive Inc  0.56 $ 1,218.891  Millions$ 2,185.198  Millions
Intercept Pharmaceuticals inc   0.56 $ 294.522  Millions$ 528.949  Millions
Sientra Inc   0.56 $ 91.708  Millions$ 164.895  Millions
Exelixis Inc   0.55 $ 1,663.870  Millions$ 3,014.406  Millions
Lemaitre Vascular Inc   0.55 $ 169.165  Millions$ 306.704  Millions
Avantor Inc   0.55 $ 7,342.300  Millions$ 13,351.100  Millions
Biocryst Pharmaceuticals Inc   0.54 $ 289.682  Millions$ 532.217  Millions
Charles River Laboratories International inc   0.54 $ 4,091.504  Millions$ 7,553.585  Millions
Merck and Co Inc   0.54 $ 57,869.000  Millions$ 107,783.000  Millions
Vertex Pharmaceuticals Inc  0.53 $ 9,208.000  Millions$ 17,353.425  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.